Salt-losing nephrogenic diabetes insipidus caused by fetal exposure to angiotensin receptor blocker

Pediatric Nephrology

Volumn 24, Issue 6, 2009, Pages 1235-1238

  Miura, Kenichiro ^a   Sekine, Takashi ^a   Iida, Atsuko ^b   Takahashi, Kazuhiro ^b   Igarashi, Takashi ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b CHIBA CHILDREN'S HOSPITAL   (Japan)

Author keywords

Angiotensin receptor blocker fetopathy; Nephrotoxicity; Urinary concentrating ability; Urine cyclic AMP; Vasopressin V2 receptor; Water restriction test

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ARGIPRESSIN; CANDESARTAN; CYCLIC AMP; INDOMETACIN;

ANURIA; ARTICLE; CASE REPORT; CHILD; CREATININE BLOOD LEVEL; DYSARTHRIA; EDEMA; FETUS DISEASE; GLOMERULUS FILTRATION RATE; HUMAN; JOINT CONTRACTURE; KIDNEY CONCENTRATING CAPACITY; KIDNEY FAILURE; KIDNEY FUNCTION; LIMB MALFORMATION; MALE; MENTAL DEFICIENCY; NEPHROGENIC DIABETES INSIPIDUS; OLIGURIA; PATENT DUCTUS ARTERIOSUS; PERITONEAL DIALYSIS; PLASMA OSMOLALITY; PLASMA RENIN ACTIVITY; POLYDIPSIA; PRENATAL DRUG EXPOSURE; PRESCHOOL CHILD; PRIORITY JOURNAL; SALT WASTING; SHORT STATURE; SKULL MALFORMATION; SODIUM EXCRETION; TUBULAR DYSFUNCTION; URIC ACID URINE LEVEL; URINE OSMOLALITY; URINE VOLUME; WATER DEPRIVATION;

ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ARGININE VASOPRESSIN; ASPARTIC ACID; CHILD; CHILD, PRESCHOOL; CYCLIC AMP; DIABETES INSIPIDUS, NEPHROGENIC; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; KIDNEY FAILURE; KIDNEY FUNCTION TESTS; MALE; PERITONEAL DIALYSIS; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; SODIUM CHLORIDE SYMPORTER INHIBITORS; TREATMENT OUTCOME; TRICHLORMETHIAZIDE;

EID: 67650326927     PISSN: 0931041X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00467-008-1091-8     Document Type: Article

References (13)

1. Guignard JP, Gouyon JB (1988) Adverse effects of drugs on the immature kidney. Biol Neonate 53:243-252
2. Pryde PG, Sedman AB, Nugent CE, Barr M Jr (1993) Angiotensin-converting enzyme inhibitor fetopathy. J Am Soc Nephrol 3:1575-1582
3. Shotan A, Widerhorn J, Hurst A, Elkayam U (1994) Risks of angiotensin-converting enzyme inhibition during pregnancy: Experimental and clinical evidence, potential mechanisms, and recommendations for use. Am J Med 96:451-456
4. Schaefer C (2003) Angiotensin II-receptor-antagonists: Further evidence of fetotoxicity but not teratogenicity. Birth Defects Res 67:591-594
5. Kemper E (1992) ACE inhibitors. Available at: http://www.fda.gov/bbs/ topics/NEWS/NEW00270.html
6. Bowen ME, Ray WA, Arbogast PG, Ding H, Cooper WO (2008) Increasing exposure to angiotensin-converting enzyme inhibitors in pregnancy. Am J Obstet Gynecol 198:291
7. Guron G, Nilsson A, Nitescu N, Nielsen S, Sundelin B, Frokler J, Friberg P (1999) Mechanisms of impaired urinary concentrating ability in adult rats treated neonatally with enalapril. Acta Physiol Scand 165:103-112
8. Chen Y, Lasaitiene D, Gabrielsson BG, Carlsson LMS, Billig H, Carlsson B, Marcussen N, Sun XF, Friberg P (2004) Neonatal losartan treatment suppresses renal expression of molecules involved in cell-cell and cell-matrix interactions. J Am Soc Nephrol 15:1232-1243
9. Woods LL, Rasch R (1998) Perinatal ANG II programs adult blood pressure, glomerular number, and renal function in rats. Am J Physiol 275:R1593-1599
10. Lasaitiene D, Friberg P, Sundelin B, Chen Y (2004) Neonatal RAS inhibition changes the phenotype of the developing thick ascending limb of Henle. Am J Physiol Renal Physiol 286:F1144-F1153
11. Guron G, Molne J, Swerkersson S, Friberg P, Hansson S (2006) A 14-year-old girl with renal abnormalities after brief intrauterine exposure to enalapril during late gestation. Nephrol Dial Transplant 21:522-525
12. Laube GF, Kemper MJ, Schubiger G, Neuhaus TJ (2007) Angiotensin-converting enzyme inhibitor fetopathy: Long-term outcome. Arch Dis Child Fetal Neonatal Ed 92:402-403
13. Sands JM, Bichet DG, American College of Physicians; American Physiological Society (2006) Nephrogenic diabetes insipidus. Ann Intern Med 7:186-194